Startup profile · funding coverage
MiRus
MiRus raised $1.5B in May 2026, one of the month's largest non-AI rounds, underscoring that medical devices can still command megaround capital.
Stage
See coverage
Status
private
Coverage
full
Why MiRus is interesting
Implantable devices depend on materials science. MiRus develops advanced alloys and implant technologies to improve durability, biocompatibility, and outcomes across spine, cardiac, and orthopedic applications. - Aging populations drive sustained implant demand. - Materials innovation can meaningfully improve patient outcomes. - The reopening exit market improves medtech funding appetite. MiRus raised $1.5B in May 2026, one of the month's largest non-AI rounds, underscoring that medical devices can still command megaround capital.
Key facts
- Disclosed financing: $1.5B
- Covered in 1 Venture Capital Tracker article(s)
Industries
Industry hub pages are rolling out from our fund-derived baseline taxonomy.
Related funding articles
Venture Capital Tracker pieces that cover MiRus's financing or category context.
Last updated: 2026-05-22